Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by ACI Healthcare USA, Inc., priced at $0.0248 per EA under NDC 71093013305. Its NADAC has been published 419 times since May 16, 2018.
Strength
850 mg/1
Manufacturer
ACI Healthcare USA, Inc.NDC
71093013305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203769On Market Since
1/15/2018
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 419 times since May 16, 2018, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0248 per EA |
|---|---|
| All-time high | $0.0316 (Sep 11, 2019) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0278 |
| Average price | $0.0270 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 419 |
| Tracking since | May 16, 2018 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by ACI Healthcare USA, Inc., is $0.0248 per EA (NDC 71093013305), effective May 20, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 13.1%. It has been tracked across 419 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since May 16, 2018, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0316 (Sep 11, 2019), with a median of $0.0278 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL 850 MG TABLET, is $0.0247 per EA — about 1% below METFORMIN HCL 850 MG TABLET.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 71093013305) is labeled by ACI Healthcare USA, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification